Literature DB >> 21804275

Abdominal symptom-related QOL in individuals visiting an outpatient clinic and those attending an annual health check.

Erina Kakuta1, Noritsugu Yamashita, Tomoko Katsube, Yoshinori Kushiyama, Hiroshi Suetsugu, Kenji Furuta, Yoshikazu Kinoshita.   

Abstract

OBJECTIVE: Quality of life (QOL) impairment of patients who visit an outpatient clinic for abdominal symptoms has not been clarified. We investigated symptom-related QOL impairment that led patients to seek medical care. PATIENTS AND METHODS: Abdominal symptom-related QOL was determined using the Izumo scale instrument in 172 patients who visited a clinic for their abdominal symptoms and in 961 healthy subjects who attended an annual health check.
RESULTS: QOL was more strongly impaired in the patients with abdominal symptoms than in subjects who attended health checks. Patients with heartburn consulted physicians even when QOL impairment was minimal, while those with epigastric fullness tended to consult a physician only when QOL impairment was significant.
CONCLUSION: Abdominal symptom-related QOL impairment is considered to lead patients to seek medical care, though different symptoms have varying levels of influence.

Entities:  

Mesh:

Year:  2011        PMID: 21804275     DOI: 10.2169/internalmedicine.50.5390

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  13 in total

1.  Evidence-based clinical practice guidelines for functional dyspepsia.

Authors:  Hiroto Miwa; Motoyasu Kusano; Tomiyasu Arisawa; Tadayuki Oshima; Mototsugu Kato; Takashi Joh; Hidekazu Suzuki; Kazunari Tominaga; Koji Nakada; Akihito Nagahara; Seiji Futagami; Noriaki Manabe; Akio Inui; Ken Haruma; Kazuhide Higuchi; Koji Yakabi; Michio Hongo; Naomi Uemura; Yoshikazu Kinoshita; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2015-01-14       Impact factor: 7.527

2.  Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study.

Authors:  Yoshikazu Kinoshita; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2011-12-21       Impact factor: 7.527

3.  Long-term vonoprazan therapy is effective for controlling symptomatic proton pump inhibitor-resistant gastroesophageal reflux disease.

Authors:  Satoshi Shinozaki; Hiroyuki Osawa; Yoshikazu Hayashi; Yoshimasa Miura; Alan Kawarai Lefor; Hironori Yamamoto
Journal:  Biomed Rep       Date:  2021-02-01

4.  A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.

Authors:  Mariko Hojo; Akihito Nagahara; Daisuke Asaoka; Tsutomu Takeda; Kentaro Izumi; Kohei Matsumoto; Hiroya Ueyama; Yuji Shimada; Kenshi Matsumoto; Shuko Nojiri; Sumio Watanabe
Journal:  Digestion       Date:  2017-06-13       Impact factor: 3.216

5.  A comparative study of the effects of daily minodronate and weekly alendronate on upper gastrointestinal symptoms, bone resorption, and back pain in postmenopausal osteoporosis patients.

Authors:  Toru Yoshioka; Nobukazu Okimoto; Ken Okamoto; Akinori Sakai
Journal:  J Bone Miner Metab       Date:  2012-10-19       Impact factor: 2.626

6.  Vonoprazan 10 mg daily is effective for the treatment of patients with proton pump inhibitor-resistant gastroesophageal reflux disease.

Authors:  Satoshi Shinozaki; Hiroyuki Osawa; Yoshikazu Hayashi; Hirotsugu Sakamoto; Yasutoshi Kobayashi; Alan Kawarai Lefor; Hironori Yamamoto
Journal:  Biomed Rep       Date:  2017-07-20

7.  Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis.

Authors:  Shingo Hatakeyama; Hiromi Murasawa; Takuma Narita; Masaaki Oikawa; Naoki Fujita; Hiromichi Iwamura; Joutaro Mikami; Yuta Kojima; Tendo Sato; Ken Fukushi; Yusuke Ishibashi; Yasuhiro Hashimoto; Takuya Koie; Hisao Saitoh; Tomihisa Funyu; Chikara Ohyama
Journal:  BMC Nephrol       Date:  2013-10-12       Impact factor: 2.388

8.  The influence of chlorella and its hot water extract supplementation on quality of life in patients with breast cancer.

Authors:  Naoto Noguchi; Isao Maruyama; Akira Yamada
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-02       Impact factor: 2.629

9.  Gastrointestinal symptom prevalence depends on disease duration and gastrointestinal region in type 2 diabetes mellitus.

Authors:  Midori Fujishiro; Akifumi Kushiyama; Hiroki Yamazaki; Sunao Kaneko; Yuko Koketsu; Takeshi Yamamotoya; Takako Kikuchi; Hideyuki Sakoda; Ryo Suzuki; Takashi Kadowaki
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

10.  Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders.

Authors:  Shino Shimura; Norihisa Ishimura; Hironobu Mikami; Eiko Okimoto; Goichi Uno; Yuji Tamagawa; Masahito Aimi; Naoki Oshima; Shuichi Sato; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  J Neurogastroenterol Motil       Date:  2016-01-31       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.